IGWM
BNGO icon

ICA Group Wealth Management’s Bionano Genomics BNGO Stock Holding History

ICA Group Wealth Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1
Closed -$39 – 842
2024
Q1 		$39 Hold
1
– – ﹤0.01% 1343
2023
Q4 		$66 Buy
+1
New +$104 ﹤0.01% 1328
2023
Q3 		– Sell
-1
Closed -$214 – 338
2023
Q2 		$214 Hold
1
– – ﹤0.01% 1291
2023
Q1 		$389 Hold
1
– – ﹤0.01% 1213
2022
Q4 		$511 Buy
+1
New +$1.26K ﹤0.01% 1232

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

ICA Group Wealth Management's BNGO Position: Q2 2024 in Review

ICA Group Wealth Management sold out of Bionano Genomics (BNGO) in Q2 2024, closing a stake of 1 share — an estimated $39 sold.

ICA Group Wealth Management first reported a position in BNGO in Q4 2022 and held it in 5 quarters. The position peaked at $511 in Q4 2022. 53 funds tracked by Wall St. Rank hold BNGO as of Q2 2024.

  • ICA Group Wealth Management reported no remaining Bionano Genomics position as of Q2 2024 after selling out during the quarter.
  • ICA Group Wealth Management sold 1 Bionano Genomics share in Q2 2024, an estimated $39.
  • ICA Group Wealth Management first reported a position in Bionano Genomics in Q4 2022 and held it in 5 quarters.
  • ICA Group Wealth Management's Bionano Genomics position peaked at $511 in Q4 2022.
  • 53 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.